ciprofloxacin has been researched along with Arterial Obstructive Diseases in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joukhadar, C | 1 |
| Klein, N | 1 |
| Frossard, M | 1 |
| Minar, E | 1 |
| Stass, H | 1 |
| Lackner, E | 1 |
| Herrmann, M | 1 |
| Riedmüller, E | 1 |
| Müller, M | 1 |
1 trial available for ciprofloxacin and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Angioplasty; Anti-Infective Agents; Area Under Curve; Arter | 2001 |